Clinical Outcomes of Ureter Stone Treatment Delayed Due To The Sars-Cov-2 Pandemic

Year 2022, , 200 - 206, 31.08.2022

Çağlar Yıldırım , Mehmet Yilmaz Salman , Mehmet Şirin Ertek , Göksel Bayar

https://doi.org/10.47493/abantmedj.1008821

Abstract

Objective: Our aim was to assess the outcomes for ureter stones with delayed treatment due to the SARS-CoV-2 pandemic.
Materials and Methods: Data from patients with ureterorenoscopy (URS) performed due to ureter stones were retrospectively assessed in the period during the pandemic of 1-31 January 2021 and the period before the pandemic of 1-31 January 2020. On first attendance, patients were assessed for emergency drainage requirements, ureter JJ stent requirement, post-op stone-free rate, re-URS requirements, and the presence of complications rated Clavien-2 and above.
Results: The study included 102 patients in total, 38 after and 64 before the pandemic. The post-pandemic group had a significantly higher impacted stone rate (15.8%) compared to the pre-pandemic group (3.1%) (p = 0.021). Seven patients (18.4%) in the first group and two patients (3.1%) in the second required emergency drainage (p = 0.008). Further, ureteral JJ stent requirements were significantly higher in the first group (71%) than in the second group (29.7%) (p<0.001). The re-URS requirements in the first group were significantly higher (18.4% vs 4.7%, p = 0.024), and in the postoperative period, stage 2 and higher complications developed in 10 patients in the first group (26.3%) and 3 patients in the second (4.7%) (p = 0.002).
Conclusion: Ureter stones with delayed treatment linked to the SARS-CoV-2 pandemic caused increased complications, permanent morbidity, and more difficult treatment processes.

Keywords

SARS-CoV-2 Pandemic, Ureter Stone, Treatment, Complication

Sars-Cov-2 Pandemisi Nedeniyle Geciktirilen Üreter Taşı Tedavisinin Klinik Sonuçları

Abstract

Amaç: SARS-CoV-2 pandemisi nedeniyle tedavisi gecikmiş üreter taşlarının sonuçlarını değerlendirmeyi amaçladık.
Gereç ve Yöntemler: Üreter taşı nedeniyle üreterorenoskopi (URS) yapılan hastalardan elde edilen veriler 1-31 Ocak 2021 pandemi döneminde ve 1-31 Ocak 2020 pandemi öncesi dönemde retrospektif olarak değerlendirildi. Acil drenaj gereksinimleri, üreter JJ stent gereksinimi, ameliyat sonrası taşsızlık oranı, yeniden URS gereksinimleri ve Clavien-2 ve üzeri olarak derecelendirilen komplikasyonlar kaydedildi.
Bulgular: Çalışmaya pandemi sonrası 38 ve pandemi öncesi 64 olmak üzere toplam 102 hasta dahil edildi. Pandemi sonrası grupta, pandemi öncesi gruba (%3,1) kıyasla önemli ölçüde daha yüksek gömülü taş oranı (%15.-,8) vardı (p = 0.021). Birinci grupta yedi hasta (%18,4) ve ikinci grupta iki hasta (%3,1) acil drenaj gerektirdi (p = 0,008). Ayrıca üreteral JJ stent gereksinimi birinci grupta (%71) ikinci gruba (%29,7) göre anlamlı derecede yüksekti (p<0.001). Birinci grupta re-URS gereksinimleri anlamlı olarak daha yüksekti (%18,4'e karşı %4,7, p=0,024). Birinci grupta 10 hastada (%26,3) ve ikinci grupta 3 hastada (%4,7) (p = 0,002) evre 2 ve üzeri komplikasyon gelişti
Sonuç: SARS-CoV-2 pandemisine bağlı tedavisi geciken üreter taşları artan komplikasyonlara, kalıcı morbiditeye ve daha zor tedavi süreçlerine neden olmuştur.

Keywords

SARS-CoV-2 Pandemisi, Üreter Taşı, Üreteroskopi, Komplikasyon

References

• 1. Proietti S, Gaboardi F, Giusti G. Endourological Stone Management in the Era of the COVID-19. Eur Urol. 2020;78:131-133.
• 2. Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JWF, Canes D. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic. Eur Urol. 2020;77:663-666.
• 3. Tefik T, Guven S, Villa L, Gokce MI, Kallidonis P, Petkova K, Kiremit MC, Sonmez MG, de Lorenzis E, Eryildirim B, Sarica K. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group. Eur Urol. 2020;78:e21-e24.
• 4. Gökce Mİ, Yin S, Sönmez MG, Eryildirim B, Kallidonis P, Petkova K, Guven S, Kiremit MC, de Lorenzis E, Tefik T, Villa L, Zeng G, Sarica K. How does the COVID-19 pandemic affect the preoperative evaluation and anesthesia applied for urinary stones? EULIS eCORE-IAU multicenter collaborative cohort study. Urolithiasis. 2020;48:345-351.
• 5. Ibrahim AK. Reporting ureteroscopy complications using the modified clavien classification system. Urol Ann. 2015;7:53-7.
• 6. Alevizopoulos A, Zosimas D, Piha L, Hanna M, Charitopoulos K. Managing Small Ureteral Stones: A Retrospective Study on Follow-Up, Clinical Outcomes and Cost-Effectiveness of Conservative Management vs. Early Surgery. Curr Urol. 2016;9:36-43.
• 7. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, De Nunzio C, Giannarini G, Gregori A, Liguori G, Mirone V, Pavan N, Scarpa RM, Simonato A, Trombetta C, Tubaro A, Porpiglia F; Research Urology Network (RUN). Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol. 2020;72:369-375.
• 8. Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JWF, Canes D. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic. Eur Urol. 2020;77:663-666.
• 9. Tugcu V, Resorlu B, Sahin S, Atar A, Kocakaya R, Eksi M, Tasci AI. Flexible Ureteroscopy versus Retroperitoneal Laparoscopic Ureterolithotomy for the Treatment of Proximal Ureteral Stones >15 mm: A Single Surgeon Experience. Urol Int. 2016;96:77-82.
• 10. Raja A, Wood F, Joshi HB. The impact of urinary stone disease and their treatment on patients' quality of life: a qualitative study. Urolithiasis. 2020;48:227-234.
• 11. Ordon M, Schuler TD, Honey RJ. Ureteral avulsion during contemporary ureteroscopic stone management: "the scabbard avulsion". J Endourol. 2011;25:1259-62.
• 12. Somani BK, Giusti G, Sun Y, Osther PJ, Frank M, De Sio M, Turna B, de la Rosette J. Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. World J Urol. 2017;35:675-681.
• 13. Boehm K, Ziewers S, Brandt MP, Sparwasser P, Haack M, Willems F, Thomas A, Dotzauer R, Höfner T, Tsaur I, Haferkamp A, Borgmann H. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective. Eur Urol. 2020;78:16-20.
• 14. Micoogullari U, Kisa E, Yucel C, Ozbilen MH, Karaca E, Cakici MC, Ozcift B, Ilbey YO. The effect of the first wave of COVID-19 pandemic on urology practice and anxiety scores of patients awaiting surgery. Int J Clin Pract. 2021;75:e14201.
• 15. Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-1681.
• 16. Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic? Patient Saf Surg. 2020;31;14:8.
• 17. Fukushima H, Kobayashi M, Kawano K, Morimoto S. Performance of Quick Sequential (Sepsis Related) and Sequential (Sepsis Related) Organ Failure Assessment to Predict Mortality in Patients with Acute Pyelonephritis Associated with Upper Urinary Tract Calculi. J Urol. 2018;199:1526-1533.